Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alessio G. Morganti, Samantha Mignogna, Luciana Caravatta, Francesco Deodato, Gabriella Macchia, Nunzio M. Plantamura, Mariangela Massaccesi, Vincenzo Picardi, Savino Cilla & Vincenzo Valentini. (2014) FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I–II study. Journal of Chemotherapy 26:6, pages 353-358.
Read now
Read now
Diane Schoenherr, Sarah A. Krueger, Lynn Martin, Laure Marignol, George D. Wilson & Brian Marples. (2013) Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: A cell line study in four glioblastoma multiforme (GBM) cell lines. International Journal of Radiation Biology 89:12, pages 1009-1016.
Read now
Read now
Nina Jeppesen Edin, Dag Rune Olsen, Joe Alexander Sandvik, Eirik Malinen & Erik Olai Pettersen. (2012) Low dose hyper-radiosensitivity is eliminated during exposure to cycling hypoxia but returns after reoxygenation. International Journal of Radiation Biology 88:4, pages 311-319.
Read now
Read now
Articles from other publishers (39)
Shingo Terashima, Hironori Yoshino, Yoshikazu Kuwahara, Hiro Sakuraba & Yoichiro Hosokawa. (2021) The Effect of High-Dose-Rate Pulsed Radiation on the Survival of Clinically Relevant Radioresistant Cells. Life 11:12, pages 1295.
Crossref
Crossref
Erica Scirocco, Francesco Cellini, Alice Zamagni, Gabriella Macchia, Francesco Deodato, Savino Cilla, Lidia Strigari, Milly Buwenge, Stefania Rizzo, Silvia Cammelli & Alessio Giuseppe Morganti. (2021) Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review. Frontiers in Oncology 11.
Crossref
Crossref
Dorota Słonina, Damian Kabat, Beata Biesaga, Anna Janecka-Widła & Wiktor Szatkowski. (2021) Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer. DNA Repair 103, pages 103113.
Crossref
Crossref
Vesna Todorovic, Ajda Prevc, Martina Niksic Zakelj, Monika Savarin, Simon Bucek, Blaz Groselj, Primoz Strojan, Maja Cemazar & Gregor Sersa. (2020) Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity. Radiology and Oncology 54:2, pages 168-179.
Crossref
Crossref
Talicia Savage, Sanjay Pandey & Chandan Guha. (2020) Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation. Clinical Cancer Research 26:4, pages 910-921.
Crossref
Crossref
Rahul R. Parikh & Biren Saraiya. (2019) Multidisciplinary Care in High-Risk Prostate Cancer Is the New Standard of Care. Journal of Clinical Oncology 37:14, pages 1143-1147.
Crossref
Crossref
V. M. Pushkarev, O. I. Kovzun, V. V. Pushkarev, B. B. Guda & M. D. Tronko. (2018) Biochemical aspects of the combined use of taxanes, irradiation and other antineoplastic agents for the treatment of anaplastic thyroid carcinoma. The Ukrainian Biochemical Journal 90:5, pages 5-18.
Crossref
Crossref
Shingo Terashima, Yoichiro Hosokawa, Eichi Tsuruga, Yasushi Mariya & Toshiya Nakamura. (2017) Impact of time interval and dose rate on cell survival following low-dose fractionated exposures. Journal of Radiation Research 58:6, pages 782-790.
Crossref
Crossref
Maria C De Santis, Luigia Nardone, Barbara Diletto, Roberta Canna, Michela Dispinzieri, Lorenza Marino, Laura Lozza & Vincenzo Valentini. (2016) Comparison of two radiation techniques for the breast boost in patients undergoing neoadjuvant treatment for breast cancer. The British Journal of Radiology 89:1066, pages 20160264.
Crossref
Crossref
Alessio Giuseppe Morganti, Francesco Cellini, Samantha Mignogna, Gilbert DA Padula, Luciana Caravatta, Francesco Deodato, Vincenzo Picardi, Gabriella Macchia, Savino Cilla, Milly Buwenge, Liberato DI Lullo, Maria Antonietta Gambacorta, Mario Balducci, Gian Carlo Mattiucci, Rosa Autorino & Vincenzo Valentini. (2016) Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study. Future Oncology 12:6, pages 779-787.
Crossref
Crossref
Natalie L. Silver, Susanne M. Arnold, John F. GleasonJrJr, Mahesh Kudrimoti, Yolanda Brill, Emily V. Dressler & Joseph Valentino. (2015) p16INK4a Status and Response to Induction Low-Dose Fractionated Radiation in Advanced Head and Neck Cancer. Annals of Otology, Rhinology & Laryngology 124:9, pages 714-720.
Crossref
Crossref
Saikat Das, J. Subhashini, Jeba Karunya Rami Reddy, Suparna KantiPal, Rajesh Isiah & Regi Oommen. (2015) Low-dose fractionated radiation and chemotherapy prior to definitive chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a prospective phase II clinical trial. Gynecologic Oncology 138:2, pages 292-298.
Crossref
Crossref
Luigia Nardone, Barbara Diletto, Maria Carmen De Santis, Giuseppe Roberto D' Agostino, Paolo Belli, Enida Bufi, Gianluca Franceschini, Antonino Mulé, Anna Sapino, Daniela Terribile & Vincenzo Valentini. (2014) Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study. The Breast 23:5, pages 597-602.
Crossref
Crossref
Lynn M. Martin, Brian Marples, Thomas H. Lynch, Donal Hollywood & Laure Marignol. (2014) Exposure to low dose ionising radiation: Molecular and clinical consequences. Cancer Letters 349:1, pages 98-106.
Crossref
Crossref
M. Balducci, B. Diletto, S. Chiesa, G.R. D’Agostino, M.A. Gambacorta, M. Ferro, C. Colosimo, G. Maira, C. Anile & V. Valentini. (2014) Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastomaNiedrigdosierte fraktionierte Strahlentherapie und gleichzeitige Chemotherapie bei rezidiviertem oder progredientem Glioblastom. Strahlentherapie und Onkologie 190:4, pages 370-376.
Crossref
Crossref
Nina Jeppesen Edin, Joe Alexander Sandvik, Hilde Synnøve Vollan, Katharina Reger, Agnes Görlach & Erik Olai Pettersen. (2013) The role of nitric oxide radicals in removal of hyper-radiosensitivity by priming irradiation. Journal of Radiation Research 54:6, pages 1015-1028.
Crossref
Crossref
Lynn M. Martin, Brian Marples, Thomas H. Lynch, Donal Hollywood & Laure Marignol. (2013) Exposure to low dose ionising radiation: Molecular and clinical consequences. Cancer Letters 338:2, pages 209-218.
Crossref
Crossref
John F. GleasonJr.Jr., Mahesh Kudrimoti, Emily M. Van Meter, Mohammed Mohiuddin, William F. Regine, Joseph Valentino, Daniel Kenady & Susanne M. Arnold. (2012) Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial. Journal of Radiation Oncology 2:1, pages 35-42.
Crossref
Crossref
David Murray, Razmik Mirzayans & Alexander J. McEwan. 2013. Nuclear Medicine Therapy. Nuclear Medicine Therapy
383
407
.
Giovanna Mantini, Vincenzo Valentini, Bruno Meduri, Stefano Margaritora, Mario Balducci, Francesco Micciché, Luigia Nardone, Fiorenza De Rose, Alfredo Cesario, Anna Rita Larici, Fabio Maggi, Maria Lucia Calcagni & Pierluigi Granone. (2012) Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: A prospective phase II study. Radiotherapy and Oncology 105:2, pages 161-166.
Crossref
Crossref
M. Balducci, S. Chiesa, B. Diletto, G. R. D'Agostino, A. Mangiola, S. Manfrida, G. Mantini, A. Albanese, A. Fiorentino, V. Frascino, B. De Bari, F. Micciche'F. De Rose, A. G. Morganti, C. Anile & V. Valentini. (2011) Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro-Oncology 14:1, pages 79-86.
Crossref
Crossref
Den? C. Wrenn, Kunal Saigal, Joseph A. LucciIIIIII, Matthew J. Pearson, Fiona Simpkins, Samer Schuman, Leo B. Twiggs, Gail R. Walker & Aaron H. Wolfson. (2011) A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium. Gynecologic Oncology 122:1, pages 59-62.
Crossref
Crossref
Sean S. Park, John L. Chunta, John M. Robertson, Alvaro A. Martinez, Ching-Yee Oliver Wong, Mitual Amin, George D. Wilson & Brian Marples. (2011) MicroPET/CT Imaging of an Orthotopic Model of Human Glioblastoma Multiforme and Evaluation of Pulsed Low-Dose Irradiation. International Journal of Radiation Oncology*Biology*Physics 80:3, pages 885-892.
Crossref
Crossref
Jun Furusawa, Haihong Zhang, Emre Vural, Annjanette Stone, Satoshi Fukuda, Nobuhiko Oridate, Hong Fang, Yanbin Ye, James Y. Suen & Chun‐Yang Fan. (2011) Distinct Epigenetic Profiling in Head and Neck Squamous Cell Carcinoma Stem Cells. Otolaryngology–Head and Neck Surgery 144:6, pages 900-909.
Crossref
Crossref
Seema Gupta, Tulay Koru-Sengul, Susanne M. Arnold, Gayathri R. Devi, Mohammed Mohiuddin & Mansoor M. Ahmed. (2011) Low-Dose Fractionated Radiation Potentiates the Effects of Cisplatin Independent of the Hyper-Radiation Sensitivity in Human Lung Cancer Cells. Molecular Cancer Therapeutics 10:2, pages 292-302.
Crossref
Crossref
Sarah A. Krueger, George D. Wilson, Evano Piasentin, Michael C. Joiner & Brian Marples. (2010) The Effects of G2-Phase Enrichment and Checkpoint Abrogation on Low-Dose Hyper-Radiosensitivity. International Journal of Radiation Oncology*Biology*Physics 77:5, pages 1509-1517.
Crossref
Crossref
David Murray & Michael Weinfeld. 2010. Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
419
471
.
Vincenzo Valentini, Mariangela Massaccesi, Mario Balducci, Giovanna Mantini, Francesco Micciché, Gian Carlo Mattiucci, Nicola Dinapoli, Bruno Meduri, Giuseppe Roberto D'Agostino, Giovanna Salvi & Luigia Nardone. (2010) Low-Dose Hyperradiosensitivity: Is There a Place for Future Investigation in Clinical Settings?. International Journal of Radiation Oncology*Biology*Physics 76:2, pages 535-539.
Crossref
Crossref
Nicolas Magné, Cyrus Chargari, Jean-Charles Soria & Eric Deutsch. (2009) Concomitant chemo-radiotherapy in clinical trials: To promote step by step rational development. Critical Reviews in Oncology/Hematology 70:3, pages 206-215.
Crossref
Crossref
Atsushi Tomioka, Motoyoshi Tanaka, Marco A. De Velasco, Satoshi Anai, Satoshi Takada, Toshihiro Kushibiki, Yasuhiko Tabata, Charles J. Rosser, Hirotsugu Uemura & Yoshihiko Hirao. (2008) Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Molecular Cancer Therapeutics 7:7, pages 1864-1870.
Crossref
Crossref
Brian Marples & Spencer J. Collis. (2008) Low-Dose Hyper-Radiosensitivity: Past, Present, and Future. International Journal of Radiation Oncology*Biology*Physics 70:5, pages 1310-1318.
Crossref
Crossref
Mohammed Momin Shareef, Brandee Brown, Shahin Shajahan, Sabapathi Sathishkumar, Susanne M. Arnold, Mohammed Mohiuddin, Mansoor M. Ahmed & Paul M. Spring. (2008) Lack of P-Glycoprotein Expression by Low-Dose Fractionated Radiation Results from Loss of Nuclear Factor-κB and NF-Y Activation in Oral Carcinoma Cells. Molecular Cancer Research 6:1, pages 89-98.
Crossref
Crossref
Brian Marples, Sarah A. Krueger, Spencer J. Collis & Michael C. Joiner. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy
329
347
.
Sarah A. Krueger, Spencer J. Collis, Michael C. Joiner, George D. Wilson & Brian Marples. (2007) Transition in Survival From Low-Dose Hyper-Radiosensitivity to Increased Radioresistance Is Independent of Activation of ATM SER1981 Activity. International Journal of Radiation Oncology*Biology*Physics 69:4, pages 1262-1271.
Crossref
Crossref
William F. Regine, Nader Hanna, Michael C. Garofalo, Austin Doyle, Susanne Arnold, Ritesh Kataria, Jacqueline Sims, Ming Tan & Mohammed Mohiuddin. (2007) Low-Dose Radiotherapy as a Chemopotentiator of Gemcitabine in Tumors of the Pancreas or Small Bowel: A Phase I Study Exploring a New Treatment Paradigm. International Journal of Radiation Oncology*Biology*Physics 68:1, pages 172-177.
Crossref
Crossref
S. A. Krueger, M. C. Joiner, M. Weinfeld, E. Piasentin & B. Marples. (2007) Role of Apoptosis in Low-Dose Hyper-radiosensitivity. Radiation Research 167:3, pages 260-267.
Crossref
Crossref
Tanguy Y Seiwert, Joseph K Salama & Everett E Vokes. (2007) The concurrent chemoradiation paradigm—general principles. Nature Clinical Practice Oncology 4:2, pages 86-100.
Crossref
Crossref
Dirk Schrijvers & Jan B Vermorken. (2005) Taxanes in the treatment of head and neck cancer. Current Opinion in Oncology 17:3, pages 218-224.
Crossref
Crossref
Susanne M Arnold, William F Regine, Mansoor M Ahmed, Joseph Valentino, Paul Spring, Mahesh Kudrimoti, Daniel Kenady, Philip Desimone & Mohammed Mohiuddin. (2004) Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. International Journal of Radiation Oncology*Biology*Physics 58:5, pages 1411-1417.
Crossref
Crossref